EMERGING TRENDS AND EVOLVING OPPORTUNITIES IN PHARMACY Dr. Amrish Chandra M.Pharm., Ph.D. AMITY UNIVERSITY, NOIDA.

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

Bruce Dickson Professor of Political Science and International Affairs George Washington University Updating the China Model.
Ranbaxy Laboratories Limited Differential Pricing & Financing of Essential Drugs Experience with Generic drugs Cecile H Miles Head of Western Europe Division.
Hale & Tempest The Global Pharmaceutical Industry (MNC & Generic) in Transition Dr. Brian W Tempest The Global Generic Summit – Barcelona,
Preparing for What’s on the Prescription Drug Benefit Horizon Brenda Motheral, PhD Senior Vice President Research & Product Management.
1 Kellogg India Business Conference 1 Mumbai as an Int’l Financial Center: Aspects of the Indian Economy India Visit 2013 George Mason University January.
PARMEE DEDHIA M.Pharm (Clinical Pharmacy), NMIMS
Health costs up 7.5%
EXTERNAL ANALYSIS, CHAPTER 2 DR. MARK FRUIN FALL 2009 BUSINESS 189.
EXTERNAL ANALYSIS, CHAPTER 2 DR. MARK FRUIN SPRING 2007 BUSINESS 189.
SUCCESS FACTORS IN THE PHARMACEUTICAL MARKETPLACE
Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest
Pre-Pharmacy Society Meeting Rocco R. Duran R.Ph Senior QA Executive – Global Quality Operations 11/10/11 Working in the pharmaceutical industry and career.
Health Care System and Reimbursements Issues in China Lu Ye School of Public Health Fudan University.
Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends Pharmaceuticals15%14% 12% 11%1.8% Hospital Inpatient Outpatient2515.
CURRENT PHARMACEUTICAL MARKETING STRATEGY M.ABHINANDANA M.PHARM Q.A.
SWOT Analysis Strengths, Weaknesses, Opportunities, Threats.
Industry Profile Pharmaceutical companies produce the drugs that save lives, and prevent illness as the population ages Large Cap pharmaceuticals are.
Challenges and Opportunities for a new Entrant in Home Furnishings
Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest
Indian retailing scenario.  According to the report ‘Strong and Steady 2011’ released by global consultancy and research firm PricewaterhouseCoopers.
Copay Structure Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
John Tuccillo Florida Realtors Challenges and Opportunities: A Commentary on Florida and the Global Economy.
Institutional Learning and Change Initiative of the CGIAR 1 The new dynamics of poverty and the role of science in poverty alleviation Javier M. Ekboir.
STRATEGIC MANAGEMENT 1 Irina Raynaud Pierre Jean Tessier Nicolas Cabrit Clément Tumoine.
PharmaSim COMPETITIVE STRATEGY
RISING MEDICAL COSTS What’s going on?. Objectives  Understand reasons behind insurance rate hikes  Things individuals can do to bring costs down  Stump.
Hale & Tempest Inhalation Drug Delivery Conference Dr. Brian W Tempest CpHI Ramada Hotel, Berlin, Germany 11 September 2013.
How to Access a Promising Market? Challenges from the Viewpoint of an Entrepreneur Interested to Access the Indian Market Norbert Gerbsch, PhD Head of.
LIST OF DRUGS COVERED BY HEALTH INSURANCE FUND OF THE REPUBLIC OF MACEDONIA Ms. Maja Parnardzieva – Zmejkova, MSc, CEO October 2011.
IMPACT OF GLOBAL TRENDS ON BUSINESSES An Evaluation of Key Factors over Next 3 Years.
Chapter Ten Local Marketing in Emerging Markets. Market analysis marketing infrastructure, income levels, currency convertibility Product strategy simplified,
India In the Midst of Change. Goals Learn about key features of India’s population Examine the state of India’s economy Understand the major challenges.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
TRENDS IN GDP IN INDIA (GROSS DOMESTIC PRODUCT) BY S. Aakash N. Ashok Kumar.
Poland The Pharma Market M. Ruzikowski. Poland - The Pharma Market Agenda: Industry Market International relation.
Chapter Seven Entrepreneurship and SMEs in the European Union (EU)
Healthcare Need & Commercial Opportunity Emerging Markets.
Impact of Economic Recovery on Irish Business Fergal O’Brien, Irish Business and Employers Confederation Danish Industries 2 nd April 2008.
PADMIN BUCH IPR Innovation & Global Market
Outline Case study: food and beverage Industry background
INDIA’S OVERSEAS INVESTMENTS A Case Study Ketaki Bhirdikar Pushkar Borse Nupur Khanna Shantala Samant.
ILKIN 2008 Marketing information over Azerbaijan. Future trends Baku 03/2008.
GLOBAL MARKET TRENDS The view from Pharma By Peter Knauer Executive Partner, Alliance Partnership.
Health Care Reform in America. The Stats 47 million people in the US do not have health insurance 792,000 people in CO do not have insurance – 1/5 of.
BUSINESS ENVIRONMENT: AN ANALYSIS DR. SK LAROIYA UNIVERSITY OF DELHI AND AMITY BUSINESS SCHOOL.
Source: National Association of Health Underwriters Education Foundation State of U.S. Healthcare 1.
Indian Product Ecosystem Santhosh P C
Allergy Drugs Markets in China Published on : Jun 2014.
Boosting Tourism in Qatar to Drive the Commercial Construction Market.
Medical Devices.
© Copyright 2004 Frost & Sullivan. All Rights Reserved. World Generics and Biogenerics Markets Regulatory and Patent Uncertainties Constrain Development.
India Pharmaceutical & Healthcare Industry 2H12 Bharat Book Bureau.
Market Data Industry Outlook & Requirements. Copyright © IT Sector Growth (Revenue) Trend IMS is emerging as a key growth driver.
LOCAL MANUFACTURING : CHALLENGES & OPPORTUNITIES
SWOT analysis.
SWOT ANALYSIS.
SWOT analysis.
Economic Growth Econ 11/30.
The Economic Impacts of Tourism
Exports and Gross Domestic Product
Exports and Gross Domestic Product
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Over-the-Counter (OTC) Drugs.
Report Code :CM 1335 India Pharmaceuticals Market Outlook 2025: Opportunity & Growth Analysis,
Report Code :CM 1335 India Pharmaceuticals Market Outlook 2025: Opportunity & Growth Analysis,
Agricultural Development in India
Capital Accumulation, Private Property and Rising Inequality in China,
Exports and Gross Domestic Product
Biosimilars Market to Reach CAGR 31.4%% by 2030 | Market Industry Reports
Market Industry Reports. Biosimilars Market is Expanding at a CAGR of 31.4% from Market Industry Reports.
Presentation transcript:

EMERGING TRENDS AND EVOLVING OPPORTUNITIES IN PHARMACY Dr. Amrish Chandra M.Pharm., Ph.D. AMITY UNIVERSITY, NOIDA

Emerging Markets

Pharma in crisis

Growth in emerging markets

India’s GDP growth

India’s contribution to global GDP

Population growth in India

Middle class population growth

Where Indians spend

Disease profile in India

Who is paying your medical bills

Role of Insurance

Key growth factors

Indian domestic market

SWOT Analysis

Mergers & Acquitions

Generics vs Branded

Innovator Branding Advantage

Why Branding?

Patents Expiring

Drug Price Control Order

OTC Advantage

Road Ahead

Rural vs Urban

Strategies

Rise in employment

The 2020 Senario

Unethical behaviour

New entrants

Prediction is difficult…

Nobel Laureate 2012

Thank you

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.